Signal Explorer
Monday, September 14 · 10-K · 10-Q · 8-K · search any ticker above
30
Filings
30
Companies
0
Signals Fired
Ipo Or Capital Raising Completion
Top Signal
Trending Classifiers
Healthcare
Reimbursement Improving
Pricing Power Services
Volume Inflecting
Other
Institutional Investment
Effective Tax Rate Reconciliation
Ipo Net Proceeds Disclosure
Share Repurchase Activity Disclosed
Quarterly Tax Provision Benefit Disclosure
Ipo Or Capital Raising Completion
Cash Flow Statement Investing Activities
Use Of Proceeds Disclosure
Revenue Increase Attribution Disclosure
Sga Expense Comparison Disclosed
SaaS
Recurring Revenue Growing
Same Client Revenue Growing
Business Services
Demand Softening
Other
Institutional Investment
Share Repurchase Activity Disclosed
Effective Tax Rate Reconciliation
Cash Flow Statement Investing Activities
Quarterly Tax Provision Benefit Disclosure
Depreciation Expense Composition Disclosure
Lease Rou Incremental Borrowing Rate Disclosure
Ipo Or Capital Raising Completion
Financing Activities Cash Flow Disclosure
Capitalized Software Amortization Disclosed
Other Income Expense Disclosure
Shares Outstanding Disclosure
Credit Risk Management Disclosure
Healthcare
Reimbursement Improving
Other
Burn Rate Controlled
Material Weakness Disclosed
Institutional Investment
Warrant Valued Black Scholes
Material Weakness In Internal Controls Disclosed
Financing Activities Cash Flow Disclosure
Share Repurchase Activity Disclosed
Net Loss Reported
Liquidity Position Snapshot Disclosed
Fair Value Hierarchy Disclosure
Reverse Stock Split Effected
Allowance For Credit Losses Methodology Disclosed
Depreciation Expense Composition Disclosure
Shares Outstanding Disclosure
Convertible Debt Conversion
Core
Indication Expansion
Lead Asset Progress
Other
Institutional Investment
Fast Track Granted
Fcpa Compliance Representation
New York Jurisdiction Clause
Ipo Net Proceeds Disclosure
Corporate Organization And Standing Representation
Nyse Listing Disclosure
Use Of Proceeds Disclosure
Sanctions Compliance Representation
Market Price Definition
Form S3 Shelf Registration Disclosure
Corporate Authority Representation
Conflicted Defense Counsel Provision
Core
Lead Asset Progress
Clinical Trial Result
Clinical Hold
Indication Expansion
Enrollment Failure
Other
Fast Track Designation Received
Institutional Investment
Fast Track Granted
Orphan Status Granted
Fda Aligned
Breakthrough Therapy Granted
Safety Differentiated
Insider Buying
Biotech Risk
Clinical Hold Active
Orphan Drug Designation
Other
Codm Segment Reporting Disclosure
Share Repurchase Activity Disclosed
Shares Outstanding Disclosure
Administrative Efficiency
Net Loss Reported
Other
Institutional Investment
Insider Buying
Nyse Listing Disclosure
Corporate Authority Representation
Fcpa Compliance Representation
New York Jurisdiction Clause
Sanctions Compliance Representation
Registration Rights Piggyback Provision
Survival Of Representations Warranties Clause
Closing Deliverables Specified
Conflicted Defense Counsel Provision
Investment Company Act Exemption Claimed
Registrant Bears Registration Expenses
Amendment Modification Waiver Clause
Nasdaq Minimum Bid Price Delisting Notice
Other
Change Of Control Definition
Debt Note Interest Terms Disclosed
Change Of Control Redemption Provision
Legal Opinion Scope Limitation
Legal Opinion Methodology Disclosure
Additional Notes Same Series Issuance
Vie Primary Beneficiary Disclosure
Event Of Default Defined
Share Withholding Tax Settlement
Employee Director Compensation Waiver
Restrictive Debt Covenants Disclosure
Core
Lead Asset Progress
Indication Expansion
Biotech v3
Ai Drug Discovery Investment
Other
Executive Educational Background Disclosure
Rsu Psu Vesting Schedule Disclosed
Employee Director Compensation Waiver
Classified Board Director Election
Board Committee Member Listing
Audit Committee Independence Certification
Gene Therapy Aav
Other
Executive Educational Background Disclosure
Classified Board Director Election
Director Continuity Stated
Other
Amendment Modification Waiver Clause
Closing Deliverables Specified
Transfer And Demand Rights Limitations
Corporate Authority Representation
No Broker Fees Representation
Corporate Organization And Standing Representation
Sanctions Compliance Representation
Hazardous Materials Definition
Use Of Proceeds Disclosure
Share Withholding Tax Settlement
Confidential Information Return Obligation
New York Jurisdiction Clause
Confidential Information Definition
Erisa Definition Or Compliance Statement
Survival Of Representations Warranties Clause
Biotech Risk
Trial Endpoint Missed
Other
Fda Aligned
Restructuring Charge Disclosed
Workforce Reduction Restructuring Plan
Interim Data Positive
Restructuring Initiated
Equity Plan Board Approval Conditional On Shareholder Vote
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Secondary Endpoint Mentioned
Combination Therapy Mentioned
Other
Quarterly Dividend Declared
Ceo Earnings Call Commentary
Core
Clinical Trial Result
Other
Publication Positive
Patient Retention High
Ai Diagnostics Investment
Interim Data Positive
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Reverse Stock Split Effected
Nyse Listing Disclosure
Merger Proxy Statement Disclosure
Fractional Share Cash Payment
Form S3 Shelf Registration Disclosure
Other
Termination For Material Breach Clause
Amendment Modification Waiver Clause
Employment Termination Upon Death
Equity Plan Board Approval Conditional On Shareholder Vote
Other
Market Price Definition
Nyse Listing Disclosure
Transfer And Demand Rights Limitations
Restrictive Debt Covenants Disclosure
Closing Deliverables Specified
Exchange Offer Letter Of Transmittal
New York Jurisdiction Clause
Related Party Loan
Other
Form S3 Shelf Registration Disclosure
Survival Of Representations Warranties Clause
Ads Depositary Procedures Disclosure
Interest Payment Date Business Day Postponement
Legal Opinion Scope Limitation
Change Of Control Redemption Provision
Closing Logistics Specified
Core
Clinical Trial Result
Lead Asset Progress
Indication Expansion
Combination Therapy Mentioned
Secondary Endpoint Mentioned
Other
Kol Endorsement
Safety Differentiated
Publication Positive
Patient Retention High
Fda Aligned
Interim Data Positive
Checkpoint Inhibitor Program
Expanded Access Program Active
Other
Tax Advisor Consultation Urged
Bitcoin Technology Description
Nyse Listing Disclosure
Ip Protection Methods Disclosed
Cost Recovery Mechanism Disclosed
Core
Clinical Trial Result
Lead Asset Progress
Secondary Endpoint Mentioned
Combination Therapy Mentioned
Other
Patient Retention High
Fda Aligned
Publication Positive
Interim Data Positive
Core
Clinical Trial Result
Lead Asset Progress
Clinical Hold
Indication Expansion
Other
Patient Retention High
Fast Track Designation Received
Fast Track Granted
Fda Aligned
Orphan Status Granted
Enrollment Ahead Of Schedule
Safety Differentiated
Publication Positive
Kol Endorsement
Rmat Designation Received
Biotech Risk
Crl Received
Core
Management Exodus
Other
Institutional Investment
Classified Board Director Election
Termination For Material Breach Clause
Nonqualified Stock Option Exercise Or Grant
Restructuring Charge Disclosed
Director Officer Indemnification Provision
Executive Expense Reimbursement Provision
Stock Option Grant Disclosed
Amendment Modification Waiver Clause
Corporate Authority Representation
Director Continuity Stated
President Duties Defined
Confidential Information Return Obligation
Survival Of Representations Warranties Clause
Other
Equity Plan Board Approval Conditional On Shareholder Vote
Core
Management Exodus
Other
Stock Certificate Signature Requirement
Employee Director Compensation Waiver
Advance Notice Requirement Disclosed
Classified Board Director Election
Equity Plan Board Approval Conditional On Shareholder Vote
Quorum Adjournment Provision
Director Continuity Stated
Director Officer Indemnification Provision
New York Jurisdiction Clause
Plan Committee Administration Clause
Other
Form S3 Shelf Registration Disclosure
Other
Equity Plan Board Approval Conditional On Shareholder Vote
Classified Board Director Election
Board Committee Composition Disclosure
Other
Nasdaq Minimum Bid Price Delisting Notice
Other
Use Of Proceeds Disclosure
Change Of Control Redemption Provision
Ipo Or Capital Raising Completion